Literature DB >> 8985096

Photobleaching of protoporphyrin IX in cells incubated with 5-aminolevulinic acid.

J Moan1, G Streckyte, S Bagdonas, O Bech, K Berg.   

Abstract

Protoporphyrin IX (Pp IX) is the main photosensitizer in photochemotherapy with 5-aminolevulinic acid (ALA). Pp IX is photolabile and the present work shows that 70-95% of Pp IX in cells is degraded by clinically relevant light exposures (40-200 J cm(-2) at 630 nm). During light exposure a small yield of photoprotoporphyrin, which is also photolabile, is formed. A substantial fraction of Pp IX in cells incubated with ALA is bound to proteins. During light exposure these binding sites are destroyed, those close to tryptophan residues being the most sensitive. The rate of photodegradation of Pp IX in the cells is dependent on the initial concentration of Pp IX. The degradation mechanisms are therefore not only first order processes. Different degradation rates appear to be related to different types of binding sites. During light exposure, Pp IX molecules appear to move to different binding sites, evidently sites that are more vital for cell survival. Thus, the yield of photoinactivation of the cells, as measured per emitted photon of Pp IX fluorescence, increased during light exposure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985096     DOI: 10.1002/(sici)1097-0215(19970106)70:1<90::aid-ijc14>3.0.co;2-h

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy.

Authors:  Asta Juzeniene; Petras Juzenas; Li-Wei Ma; Vladimir Iani; Johan Moan
Journal:  Lasers Med Sci       Date:  2004-10-16       Impact factor: 3.161

2.  Scanning Fiber Endoscope Improves Detection of 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence at the Boundary of Infiltrative Glioma.

Authors:  Evgenii Belykh; Eric J Miller; Danying Hu; Nikolay L Martirosyan; Eric C Woolf; Adrienne C Scheck; Vadim A Byvaltsev; Peter Nakaji; Leonard Y Nelson; Eric J Seibel; Mark C Preul
Journal:  World Neurosurg       Date:  2018-02-02       Impact factor: 2.104

Review 3.  Beyond the margins: real-time detection of cancer using targeted fluorophores.

Authors:  Ray R Zhang; Alexandra B Schroeder; Joseph J Grudzinski; Eben L Rosenthal; Jason M Warram; Anatoly N Pinchuk; Kevin W Eliceiri; John S Kuo; Jamey P Weichert
Journal:  Nat Rev Clin Oncol       Date:  2017-01-17       Impact factor: 66.675

4.  Laser-induced effects in different biological samples.

Authors:  M Atif; S Firdous; M Nawaz
Journal:  Lasers Med Sci       Date:  2010-02-20       Impact factor: 3.161

5.  Phototoxicity of 5-aminolevulinic acid in the HeLa cell line as an indicative measure of photodynamic effect after topical administration to gynecological lesions of intraepithelial form.

Authors:  Paul A McCarron; Ryan F Donnelly; Brendan F Gilmore; A David Woolfson; Raymond McClelland; Agnieszka Zawislak; John H Price
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

6.  Specific intensity imaging for glioblastoma and neural cell cultures with 5-aminolevulinic acid-derived protoporphyrin IX.

Authors:  Frank Duffner; Rainer Ritz; Dirk Freudenstein; Michael Weller; Klaus Dietz; Johannes Wessels
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

7.  Autoradiographic and scintillation analysis of 5-aminolevulinic acid permeation through epithelialised tissue: implications for topical photodynamic therapy of superficial gynaecological neoplasias.

Authors:  Paul A McCarron; Ryan F Donnelly; A David Woolfson
Journal:  Pharm Res       Date:  2007-07-27       Impact factor: 4.200

Review 8.  Photophysics and photochemistry of photodynamic therapy: fundamental aspects.

Authors:  K Plaetzer; B Krammer; J Berlanda; F Berr; T Kiesslich
Journal:  Lasers Med Sci       Date:  2008-02-05       Impact factor: 3.161

9.  In vivo photobleaching kinetics and epithelial biodistribution of hexylaminolevulinate-induced protoporphyrin IX in rat bladder cancer.

Authors:  Sami El Khatib
Journal:  Curr Urol       Date:  2021-03-29

10.  In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells.

Authors:  Rainer Ritz; Christian Scheidle; Susan Noell; Florian Roser; Martin Schenk; Klaus Dietz; Wolfgang S L Strauss
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.